newsfilter
← Latest News
Business Wire·

Verastem Oncology Appoints Michael P. Bailey to its Board of Directors

Verastem Oncology (NASDAQ:VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced the appointment of Michael P. Bailey to its Board of